Latest Period
Q2 2026
Security Snapshot
Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share (CLRB) Institutional Ownership
CUSIP: 15117F880
13F Institutional Holders and Ownership History from Q2 2025 to Q2 2026
Institutions Reporting
28
Shares (Excl. Options)
3,249,237
Price
$2.78
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, $0.00001 par value per share
- Symbol
- CLRB on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 3,249,237
- Total 13F value
- $9,030,063
- Portfolio coverage rank
- 0%
- Share change
- +2,674,745
- Value change
- +$7,439,370
- Number of holders
- 28
- Shares outstanding
- 7,966,068
- SEC-reported price per share
- $2.63
- Insider filing price
- $2.63
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- CLRB - Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share is tracked under CUSIP 15117F880.
- 28 institutions reported positions in Q2 2026.
- 11 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 18 to 28 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $762,852 to $9,030,063.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 28 institutions filings for Q2 2026.
Security key
15117F880
Latest holder period
Q2 2026
13F holders
28
13D/G owners
11
CIK / CUSIP context first
Open Q2 2026 holders
CLRB full holder history
Cellectar Biosciences, Inc. SEC filings
Cellectar Biosciences, Inc. company facts
Cellectar Biosciences, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 15117F880:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
11
Security
CLRB
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Empery Asset Management, LP | 10% | $2,272,557 | 864,090 | Empery Asset Management, LP | 30 Jun 2026 | |||
| SILVERARC CAPITAL MANAGEMENT, LLC | 10% | $2,238,880 | 851,285 | SilverArc Capital Management, LLC | 30 Jun 2026 | |||
| STEMPOINT CAPITAL LP | 9.9% | $2,224,296 | 845,740 | StemPoint Capital LP | 30 Jun 2026 | |||
| Bleichroeder LP | 10% | +108% | $2,125,829 | +$1,599,829 | 808,300 | +304% | Bleichroeder LP | 30 Jun 2026 |
| BALYASNY ASSET MANAGEMENT L.P. | 10% | $2,099,745 | 798,382 | BALYASNY ASSET MANAGEMENT L.P. | 30 Jun 2026 | |||
| JANUS HENDERSON GROUP PLC | 10% | $2,347,243 | 798,382 | JANUS HENDERSON GROUP PLC | 29 May 2026 | |||
| Caligan Partners LP | 5.9% | $1,236,095 | 469,998 | Caligan Partners LP | 30 Jun 2026 | |||
| Hexstone Capital LLC | 4.9% | -12% | $553,293 | +$169,293 | 216,130 | +44% | Hexstone Capital LLC | 31 Dec 2025 |
| INTRACOASTAL CAPITAL, LLC | 5% | 140,101 | Mitchell P. Kopin | 01 Jul 2025 | ||||
| LYTTON LAURENCE W | 1.6% | $250,788 | 51,391 | LYTTON LAURENCE W | 30 Jun 2025 | |||
| Nantahala Capital Management, LLC | 0.06% | $5,412 | 1,109 | Nantahala Capital Management, LLC | 30 Jun 2025 |
As of 30 Jun 2026, 28 institutional investors reported holding 3,249,237 shares of Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share (CLRB). This represents 41% of the company’s total 7,966,068 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
41%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Caligan Partners LP | 5.9% | 469,998 | 0.06% | $1,306,594 | |
| STEMPOINT CAPITAL LP | 4.5% | 354,938 | 0.17% | $986,728 | |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.1% | 327,367 | +300% | 0% | $910,080 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 4% | 321,728 | 0.1% | $894,404 | |
| Bleichroeder LP | 3.6% | 288,679 | +189% | 0.14% | $802,528 |
| Jupiter Topco LLC | 3.4% | 274,156 | 0% | 0% | $759,412 |
| Balyasny Asset Management L.P. | 2.8% | 220,000 | 0% | $611,600 | |
| Nantahala Capital Management, LLC | 2.8% | 219,998 | 0.04% | $611,594 | |
| Empery Asset Management, LP | 2.4% | 189,605 | 0.61% | $527,102 | |
| DIADEMA PARTNERS LP | 1.7% | 138,341 | 0.15% | $384,588 | |
| Stonepine Capital Management, LLC | 1.3% | 104,550 | 0.19% | $290,649 | |
| Persistent Asset Partners Ltd | 1.2% | 92,983 | 0.08% | $258,493 | |
| BOOTHBAY FUND MANAGEMENT, LLC | 1.1% | 85,069 | 0% | $236,492 | |
| GEODE CAPITAL MANAGEMENT, LLC | 0.67% | 53,351 | +1.1% | 0% | $148,323 |
| VANGUARD FIDUCIARY TRUST CO | 0.58% | 46,220 | +179% | 0% | $128,492 |
| Sequoia Financial Advisors, LLC | 0.27% | 21,850 | +16% | 0% | $60,743 |
| ACADIAN ASSET MANAGEMENT LLC | 0.21% | 16,577 | 0% | $46,000 | |
| NORTHERN TRUST CORP | 0.19% | 14,839 | 0% | $41,252 | |
| BlackRock, Inc. | 0.06% | 4,735 | -0.21% | 0% | $13,163 |
| UBS Group AG | 0.04% | 3,093 | -68% | 0% | $8,599 |
| BARCLAYS PLC | 0.01% | 561 | 0% | $1,560 | |
| MORGAN STANLEY | 0.01% | 510 | 0% | 0% | $1,418 |
| TD Waterhouse Canada Inc. | 0% | 63 | 0% | 0% | $178 |
| SBI Securities Co., Ltd. | 0% | 11 | 0% | 0% | $31 |
| OSAIC HOLDINGS, INC. | 0% | 7 | +600% | 0% | $18 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
5
Latest
Q2 2026
Rows shown
1-5 of 5
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 3,249,237 | $9,030,063 | +$7,439,370 | $2.78 | 28 |
| 2026 Q1 | 300,336 | $762,852 | -$145,445 | $2.54 | 18 |
| 2025 Q4 | 336,454 | $992,540 | -$210 | $2.95 | 19 |
| 2025 Q3 | 296,154 | $1,650,372 | +$1,061,105 | $5.60 | 21 |
| 2025 Q2 | 103,397 | $734,048 | +$734,048 | $7.11 | 19 |